Reinier C A van Linschoten, C Janneke van der Woude, Elyke Visser, Nikki van Leeuwen, Alexander G L Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K Evelyne Verweij, Sanne van der Wiel, Daan Nieboer, Erwin Birnie, Daniëlle van der Horst, Jan A Hazelzet, Desirée van Noord, Rachel L West
BACKGROUND: Data on variation in outcomes and costs of the treatment of inflammatory bowel disease (IBD) can be used to identify areas for cost and quality improvement. It can also help healthcare providers learn from each other and strive for equity in care. We aimed to assess the variation in outcomes and costs of IBD care between hospitals. METHODS: We conducted a 12-month cohort study in 8 hospitals in the Netherlands. Patients with IBD who were treated with biologics and new small molecules were included...
April 26, 2024: Inflammatory Bowel Diseases